{"id":61,"date":"2026-03-12T22:09:29","date_gmt":"2026-03-12T22:09:29","guid":{"rendered":"https:\/\/beatcancercoalition.org\/?page_id=61"},"modified":"2026-10-13T21:03:13","modified_gmt":"2026-10-13T21:03:13","slug":"our-work","status":"publish","type":"page","link":"https:\/\/beatcancercoalition.org\/fr\/our-work","title":{"rendered":"NOTRE TRAVAIL"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

IMPACT & RECHERCHE<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Notre travail<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

L\u2019acc\u00e8s \u00e9quitable aux tests de biomarqueurs et aux soins oncologiques personnalis\u00e9s doit \u00eatre une norme de soins pour tous les patients au Canada, quel que soit leur \u00e2ge, leur lieu de r\u00e9sidence ou leur revenu.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Policy Brief (October 2026)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ahead of the Federal, Provincial and Territorial (FPT) Health Ministers\u2019 meeting, the BEAT Cancer Coalition urges ministers to advance timely and equitable access to clinically appropriate biomarker testing for cancer patients across Canada.<\/span>\u00a0<\/span><\/p>

Biomarker testing can help healthcare teams identify suitable treatments and clinical trials, but differences in funding, laboratory capacity and testing pathways mean access can depend on where patients live or their ability to pay.<\/span>\u00a0<\/span><\/p>

This policy brief outlines three priorities for action: improving education and navigation, strengthening testing capacity and pathways, and coordinating funding, standards and accountability across Canada.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

\u201cRight test. Right time. Every patient.\u201d<\/span><\/i>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDownload Policy Brief<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Department of Finance: Pre-Budget Submission (September 2026)\u00a0<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The BEAT Cancer Coalition recommends a federal investment of $25 million over five years, beginning in 2027\u201328, to advance timely and equitable access to clinically appropriate biomarker testing across Canada.<\/span>\u00a0<\/span><\/p>

Submitted to the Department of Finance for the pre-budget consultations, this report presents evidence on the potential benefits of biomarker testing for patients and the healthcare system. It outlines investments in education, laboratory and workforce capacity, digital systems and coordinated testing pathways.<\/span>\u00a0<\/span><\/p>

Developed in collaboration with provinces, territories and cancer-system stakeholders, the proposed initiative would help ensure testing results are available, understood and acted upon in time to guide care.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

\u201cAccess determined by clinical need and evidence, not geography or ability to pay.\u201d<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDownload Pre-Budget Submission\u00a0<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Document de politique (juillet 2022)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

La Coalition pour Vaincre le Cancer recommande que les gouvernements permettent un acc\u00e8s \u00e9quitable aux tests diagnostiques mol\u00e9culaires avanc\u00e9s appropri\u00e9s, notamment le profilage g\u00e9nomique complet (CGP), pour tous les patients atteints de cancer au Canada.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Les traitements contre le cancer ont consid\u00e9rablement \u00e9volu\u00e9 au cours des derni\u00e8res d\u00e9cennies, avec une transition vers des soins plus personnalis\u00e9s ax\u00e9s sur les besoins de chaque patient. Les th\u00e9rapies contre le cancer sont d\u00e9sormais d\u00e9velopp\u00e9es en fonction des moteurs mol\u00e9culaires cl\u00e9s pr\u00e9sents dans le profil g\u00e9nomique des tumeurs individuelles.<\/p>

Malgr\u00e9 ces avanc\u00e9es, les patients continuent de subir une approche de traitement uniforme, avec un acc\u00e8s limit\u00e9 aux diagnostics avanc\u00e9s et des cycles de traitement successifs qui peuvent ou non \u00eatre efficaces.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

\u00ab 63 % des patients ne connaissent pas les traitements guid\u00e9s par biomarqueurs au moment du diagnostic. \u00bb<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tT\u00e9l\u00e9charger le document de politique<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u00ab Tous les patients en oncologie au Canada, peu importe leur lieu de r\u00e9sidence, devraient recevoir des tests mol\u00e9culaires avanc\u00e9s appropri\u00e9s et en temps opportun afin de b\u00e9n\u00e9ficier du traitement optimal, leur offrant les meilleures chances de succ\u00e8s th\u00e9rapeutique et la meilleure opportunit\u00e9 de vivre pleinement leur vie. \u00bb<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

S\u00e9rie vid\u00e9o sur les tests de biomarqueurs<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00c9coutez directement des experts canadiens expliquer ce que sont les tests de biomarqueurs, comment ils fonctionnent et la valeur qu\u2019ils apportent aux patients atteints de cancer.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

\u00ab Les tests de biomarqueurs r\u00e9v\u00e8lent le profil mol\u00e9culaire unique d\u2019une tumeur \u2014 c\u2019est ainsi que nous garantissons le bon traitement pour le bon patient au bon moment. \u00bb \u2014 Dr Brandon Sheffield<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
English<\/h5>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
French<\/h5>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
English<\/h5>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
French<\/h5>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

GR\u00c2CE AU SOUTIEN DE :<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Roche\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Colorectal\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

L\u2019acc\u00e8s \u00e9quitable aux tests de biomarqueurs et aux soins oncologiques personnalis\u00e9s doit \u00eatre une norme de soins pour tous les patients au Canada, quel que soit leur \u00e2ge, leur lieu de r\u00e9sidence ou leur revenu.<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-61","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/pages\/61","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/comments?post=61"}],"version-history":[{"count":82,"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/pages\/61\/revisions"}],"predecessor-version":[{"id":869,"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/pages\/61\/revisions\/869"}],"wp:attachment":[{"href":"https:\/\/beatcancercoalition.org\/fr\/wp-json\/wp\/v2\/media?parent=61"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}